Overview
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist designed for research purposes with approximately 7-day half-life, enabling convenient once-weekly subcutaneous dosing. This educational protocol outlines a gradual weekly titration schedule from 0.25 mg to a maintenance dose of 2.4 mg over 16+ weeks.
Quick Reference
– Reconstitution: 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration
– Dosing Range: 250–2400 mcg weekly (once per week)
– Measurement Guide: 1 unit = 0.01 mL ≈ 66.7 mcg on U-100 insulin syringe
– Storage (Lyophilized): -20°C (-4°F)
– Storage (Reconstituted): 2–8°C (35.6–46.4°F); use within 28 days
Standard Titration Protocol
| Week Range | Weekly Dose | Insulin Syringe Units | Volume (mL) |
|---|---|---|---|
| 1–4 | 250 mcg (0.25 mg) | 4 units | 0.04 mL |
| 5–8 | 500 mcg (0.5 mg) | 7.5 units | 0.075 mL |
| 9–12 | 1000 mcg (1.0 mg) | 15 units | 0.15 mL |
| 13–16 | 1700 mcg (1.7 mg) | 25.5 units | 0.255 mL |
| 17+ (Maintenance) | 2400 mcg (2.4 mg) | 36 units | 0.36 mL |
Frequency: Once weekly via subcutaneous injection on the same day each week.
Reconstitution Instructions
1. Draw 3.0 mL bacteriostatic water with sterile syringe
2. Inject slowly down vial wall to minimize foaming; avoid shaking
3. Gently swirl or roll vial until powder fully dissolves
4. Label with reconstitution date and refrigerate at 2–8°C
5. Use within 28 days for optimal potency and safety
Supplies Needed
Per Protocol Duration:
– Peptide Vials: 1 vial covers ~8 weeks (3 mg used); 2 vials for 20 weeks with maintenance dosing
– Insulin Syringes (U-100): 1 per week of protocol
– Bacteriostatic Water (10 mL bottles): 3 mL per vial reconstitution
– Alcohol Swabs: 2 per weekly injection (100-count box recommended)
Storage Instructions
Lyophilized Form:
– Store at −20°C (−4°F) in cool, dry location away from light
– Short-term: 2–8°C (35.6–46.4°F) acceptable for months
– Prevent humidity exposure
Reconstituted Solution:
– Refrigerate at 2–8°C; do not freeze
– Use within 28 days maximum
– Benzyl alcohol in bacteriostatic water provides antimicrobial protection
How It Works
Semaglutide demonstrates 94% sequence homology to native human GLP-1, functioning through multiple mechanisms: appetite reduction via central nervous system effects, delayed gastric emptying, and improved glycemic control through glucose-dependent insulin secretion. The extended 7-day half-life results from albumin binding and resistance to DPP-4 degradation. Clinical trials demonstrate mean weight loss of 10–15% body weight reduction at 2.4 mg weekly when combined with lifestyle interventions.
Injection Technique
– Clean vial stopper and injection site separately with alcohol swabs; allow to dry completely
– Pinch skin fold; insert needle at 45–90° angle into subcutaneous tissue (fatty layer, not muscle)
– Do not aspirate (pull back plunger)
– Inject slowly and steadily; wait 6+ seconds before withdrawing needle
– Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent lipohypertrophy
– Dispose of syringes in proper FDA-approved sharps container
Potential Benefits
– Significant weight loss (10–15% body weight reduction) combined with lifestyle modifications
– Enhanced glycemic control through glucose-dependent insulin secretion
– Reduced appetite and food intake
– Cardiovascular benefits including reduced major adverse cardiovascular events
– Convenient once-weekly dosing improves adherence
Potential Side Effects
Common (typically mild-to-moderate, decrease with gradual titration):
– Nausea, vomiting, diarrhea, constipation, abdominal pain
Injection-related:
– Redness, swelling, or irritation at injection site
Less Common:
– Hypoglycemia (when combined with insulin or sulfonylureas)
– Pancreatitis, gallbladder disease, acute kidney injury
– Thyroid C-cell tumors observed in rodent studies (human relevance uncertain)
Important Considerations
– Use new sterile syringes for each injection
– Rotate injection sites systematically to reduce irritation and avoid lipohypertrophy
– Administer on consistent day each week; if missed, take within 5 days
– Gradual dose escalation minimizes gastrointestinal side effects
– The 20 mg vial provides excellent economy, lasting 16+ weeks through escalation phase
Lifestyle Factors for Optimal Outcomes
– Maintain balanced, calorie-controlled diet with adequate protein (1.2–1.6 g/kg body weight)
– Combine resistance training (2–3 days weekly) and aerobic exercise (150+ minutes weekly)
– Prioritize consistent sleep (7–9 hours nightly) and stress management
– Stay well-hydrated (8–10 glasses water daily)
– Monitor progress through regular weigh-ins, measurements, and professional consultation
– Consider registered dietitian guidance for personalized nutrition
Disclaimer
This content is for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. Semaglutide is for research use only and not intended for human consumption. Always consult qualified healthcare professionals before considering any peptide therapy.